468 related articles for article (PubMed ID: 33741974)
1. Epigenetic mechanisms in breast cancer therapy and resistance.
Garcia-Martinez L; Zhang Y; Nakata Y; Chan HL; Morey L
Nat Commun; 2021 Mar; 12(1):1786. PubMed ID: 33741974
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer.
Toska E
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189097. PubMed ID: 38518961
[TBL] [Abstract][Full Text] [Related]
3. Endocrine resistance in breast cancer: from cellular signaling pathways to epigenetic mechanisms.
Bianco S; Gévry N
Transcription; 2012; 3(4):165-70. PubMed ID: 22771991
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response.
Pathiraja TN; Stearns V; Oesterreich S
J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):35-47. PubMed ID: 20101445
[TBL] [Abstract][Full Text] [Related]
5. Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer.
Salvati A; Gigantino V; Nassa G; Mirici Cappa V; Ventola GM; Cracas DGC; Mastrocinque R; Rizzo F; Tarallo R; Weisz A; Giurato G
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517194
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Control of Cancer Cell Dormancy and Awakening in Endocrine Therapy Resistance.
Llinas-Bertran A; Bellet-Ezquerra M; Seoane JA
Cancer Discov; 2024 May; 14(5):704-706. PubMed ID: 38690600
[TBL] [Abstract][Full Text] [Related]
7. Endocrine-resistant breast cancer: underlying mechanisms and strategies for overcoming resistance.
Kurebayashi J
Breast Cancer; 2003; 10(2):112-9. PubMed ID: 12736563
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.
Zilli M; Grassadonia A; Tinari N; Di Giacobbe A; Gildetti S; Giampietro J; Natoli C; Iacobelli S;
Biochim Biophys Acta; 2009 Jan; 1795(1):62-81. PubMed ID: 18804516
[TBL] [Abstract][Full Text] [Related]
9. Epigenomics and breast cancer.
Lo PK; Sukumar S
Pharmacogenomics; 2008 Dec; 9(12):1879-902. PubMed ID: 19072646
[TBL] [Abstract][Full Text] [Related]
10. Overcoming endocrine resistance in hormone receptor-positive breast cancer.
AlFakeeh A; Brezden-Masley C
Curr Oncol; 2018 Jun; 25(Suppl 1):S18-S27. PubMed ID: 29910644
[TBL] [Abstract][Full Text] [Related]
11. Role of epigenetic modifications in luminal breast cancer.
Abdel-Hafiz HA; Horwitz KB
Epigenomics; 2015 Aug; 7(5):847-62. PubMed ID: 25689414
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
13. Biological mechanisms and clinical implications of endocrine resistance in breast cancer.
Giuliano M; Schifp R; Osborne CK; Trivedi MV
Breast; 2011 Oct; 20 Suppl 3():S42-9. PubMed ID: 22015292
[TBL] [Abstract][Full Text] [Related]
14. Overcoming endocrine resistance in breast cancer.
Madaio RA; Spalletta G; Cravello L; Ceci M; Repetto L; Naso G
Curr Cancer Drug Targets; 2010 Aug; 10(5):519-28. PubMed ID: 20384578
[TBL] [Abstract][Full Text] [Related]
15. Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals.
Szostakowska M; Trębińska-Stryjewska A; Grzybowska EA; Fabisiewicz A
Breast Cancer Res Treat; 2019 Feb; 173(3):489-497. PubMed ID: 30382472
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.
Achinger-Kawecka J; Valdes-Mora F; Luu PL; Giles KA; Caldon CE; Qu W; Nair S; Soto S; Locke WJ; Yeo-Teh NS; Gould CM; Du Q; Smith GC; Ramos IR; Fernandez KF; Hoon DS; Gee JMW; Stirzaker C; Clark SJ
Nat Commun; 2020 Jan; 11(1):320. PubMed ID: 31949157
[TBL] [Abstract][Full Text] [Related]
17. SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer.
Perone Y; Farrugia AJ; Rodríguez-Meira A; Győrffy B; Ion C; Uggetti A; Chronopoulos A; Marrazzo P; Faronato M; Shousha S; Davies C; Steel JH; Patel N; Del Rio Hernandez A; Coombes C; Pruneri G; Lim A; Calvo F; Magnani L
Nat Commun; 2019 May; 10(1):2115. PubMed ID: 31073170
[TBL] [Abstract][Full Text] [Related]
18. Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies.
Murphy CG; Dickler MN
Endocr Relat Cancer; 2016 Aug; 23(8):R337-52. PubMed ID: 27406875
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptors in resistance to hormone therapy.
Herynk MH; Fuqua SA
Adv Exp Med Biol; 2007; 608():130-43. PubMed ID: 17993238
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance.
Raha P; Thomas S; Munster PN
Epigenomics; 2011 Aug; 3(4):451-70. PubMed ID: 22126205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
